| payload |
{"created_at":"2026-04-22T11:09:42.515 {"created_at":"2026-04-22T11:09:42.515872+00:00","dedupe_key":"signal_enriched:discovery_unusual_volume_delta:4bc197484a288a76","evidence_event_ids":["evt_b9dec0d558e5"],"signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","value":{"aggregator_url":"https://www.nasdaq.com/articles/boston-scientific-corp-announces-climb-q1-bottom-line","as_of":"2026-04-22T11:09:42.515872+00:00","canonical_url":"https://www.rttnews.com/3641172/boston-scientific-corp-announces-climb-in-q1-bottom-line.aspx","enrichment":{"aggregator_url":"https://www.nasdaq.com/articles/boston-scientific-corp-announces-climb-q1-bottom-line","article_chars":958,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_0196724edecc66df","canonical_host":"rttnews.com","canonical_is_aggregator":false,"canonical_url":"https://www.rttnews.com/3641172/boston-scientific-corp-announces-climb-in-q1-bottom-line.aspx","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-22T11:11:51.799693+00:00","extraction_method":"trafilatura","fetched_description":"(RTTNews) - Boston Scientific Corp (BSX) reported a profit for its first quarter that Increases, from last year","fetched_title":"Boston Scientific Corp Announces Climb In Q1 Bottom Line | Nasdaq","final_url":"https://www.nasdaq.com/articles/boston-scientific-corp-announces-climb-q1-bottom-line","html_truncated":false,"paywall_likely":false,"publisher_domain":"rttnews.com","publisher_resolution":"canonical_url","requested_url":"https://www.nasdaq.com/articles/boston-scientific-corp-announces-climb-q1-bottom-line","source_event_id":"evt_b9dec0d558e5","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"fp":"92e766ac97c123a0","kind":"unusual_volume","published_at":"2026-04-22T10:34:33+00:00","publisher_domain":"rttnews.com","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":[],"entities":[{"asset_class":"equity","name":"Boston Scientific Corp","relevance":"high","symbol":"BSX","type":"company"}],"event_type":"earnings","information_gaps":["No unusual trading volume data is provided (baseline volume, current volume, or volume ratio vs average are missing).","No explicit statement confirms whether any volume spike is confirmed by news or is unexplained.","No volume-related catalyst hypothesis is stated in the provided text; only earnings/guidance information is given."],"key_facts":["Q1 bottom line: $1.34 billion, or $0.90 per share.","Prior-year Q1 bottom line: $674 million, or $0.45 per share.","Adjusted earnings (excluding items): $1.18 billion, or $0.80 per share.","Revenue rose 11.6% to $5.20 billion from $4.66 billion last year.","Next quarter EPS guidance: $0.82 to $0.84.","Next quarter revenue guidance: 5.5% to 7.5%.","Full year EPS guidance: $3.34 to $3.41.","Full year revenue guidance: 7.0% to 8.5%."],"numeric_claims":[{"label":"Q1 bottom line (GAAP) profit","value":"$1.34 billion"},{"label":"Q1 EPS (GAAP)","value":"$0.90"},{"label":"Prior-year Q1 bottom line (GAAP) profit","value":"$674 million"},{"label":"Prior-year Q1 EPS (GAAP)","value":"$0.45"},{"label":"Q1 adjusted earnings (excluding items)","value":"$1.18 billion"},{"label":"Q1 adjusted EPS (excluding items)","value":"$0.80"},{"label":"Q1 revenue","value":"$5.20 billion"},{"label":"Prior-year Q1 revenue","value":"$4.66 billion"},{"label":"Revenue growth rate (YoY)","value":"11.6%"},{"label":"Next quarter EPS guidance range","value":"$0.82 to $0.84"},{"label":"Next quarter revenue guidance range","value":"5.5% to 7.5%"},{"label":"Full year EPS guidance range","value":"$3.34 to $3.41"},{"label":"Full year revenue guidance range","value":"7.0% to 8.5%"}],"primary_claim":"Boston Scientific Corp (BSX) reported Q1 bottom-line profit of $1.34 billion ($0.90/share), up from $674 million ($0.45/share) last year, alongside revenue rising to $5.20 billion (+11.6%).","relevance_score":0.62,"sentiment":"positive","source_quality":"medium","summary":"RTTNews reports Boston Scientific (BSX) posted higher Q1 profit and revenue year-over-year, with provided GAAP and adjusted EPS figures plus forward guidance. The signal is about unusual volume, but the article text does not include any volume ratio or volume confirmation details.","topics":["Q1 earnings","profit increase","EPS","revenue growth","earnings guidance"]},"source":"Nasdaq Markets","source_domain":"rttnews.com","summary":"(RTTNews) - Boston Scientific Corp (BSX) reported a profit for its first quarter that Increases, from last year","tickers":["BSX"],"title":"Boston Scientific Corp Announces Climb In Q1 Bottom Line","url":"https://www.rttnews.com/3641172/boston-scientific-corp-announces-climb-in-q1-bottom-line.aspx"}}... |